At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19.
HelixNano’s ultimate mission is to build technologies that unlock a future where freedom from cancer is a fundamental human right. But right now, the fight against a global pandemic needs all scientific hands on deck. In response to this existential challenge, our team is applying its expertise to deploy a novel vaccination approach against COVID-19.
Total Funding: $6,354,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2C
Company Size: 1 to 25
Founded: 2013
